urico-lowering therapy
Showing 26 - 50 of >10,000
Stroke Research Consortium in Northern Bavaria (STAMINA)
Completed
- Ischemic Stroke
- thrombolysis therapy
- +5 more
-
Erlangen, Germany
- +1 more
Jul 29, 2022
Sperm Quality of Male Gouty Patients:A Prospective Cohort Study
Recruiting
- Gout
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 16, 2021
Gout Trial in Birmingham (Denosumab)
Completed
- Gout
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 22, 2021
A 52-week Post-marketing, Observational Study to Confirm Safety
Completed
- Hypercholesterolemia
- +2 more
- Ezetimibe
- Ezetimibe + other lipid-lowering medication(s)
- (no location specified)
Feb 7, 2022
A 12-week Post-marketing, Observational Study to Confirm Safety
Completed
- Hypercholesterolemia
- +2 more
- Ezetimibe
- Ezetimibe + other lipid-lowering medication(s)
- (no location specified)
Feb 7, 2022
Type 2 Diabetes, Inadequate Glucose Control Trial in Busan (duvie)
Completed
- Type 2 Diabetes Mellitus
- Inadequate Glucose Control
-
Busan, Korea, Republic ofPusan National University Hospital
Jan 4, 2022
Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)
Active, not recruiting
- Heterozygous Familial Hypercholesterolemia
-
Cincinnati, Ohio
- +6 more
Nov 3, 2022
Hypercholesteremia, Ultrasound Therapy Trial in Nanjing (High-intensity focused ultrasound, Sham treatment)
Active, not recruiting
- Hypercholesteremia
- Ultrasound Therapy
- High-intensity focused ultrasound
- Sham treatment
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital / The First Affiliated Hospital of Nan
Oct 15, 2021
Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)
Enrolling by invitation
- Hypercholesterolemia
- Atherosclerotic Ischemic Disease
- lerodalcibep
- Inclisiran
-
Nantes, Cedex 01, France
- +6 more
Nov 3, 2022
Metabolic Syndrome Trial in Chongqing (Hypoglycemic drugs, Bariatric surgery)
Recruiting
- Metabolic Syndrome
- Hypoglycemic drugs
- Bariatric surgery
-
Chongqing, Chongqing, ChinaStryker Laparoscopy
May 16, 2022
Hypercholesterolemia, Cardiovascular Diseases Trial in Cincinnati (lerodalcibep, evolocumab, alirocumab)
Active, not recruiting
- Hypercholesterolemia
- Cardiovascular Diseases
- lerodalcibep
- +2 more
-
Cincinnati, Ohio
- +2 more
Jul 13, 2022
Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke Trial in India, Israel, United States (lerodalcibep,
Active, not recruiting
- Cardiovascular Risk Factor
- +3 more
- lerodalcibep
- Placebo
-
Cincinnati, Ohio
- +5 more
Nov 3, 2022
Acute Kidney Injury, Renal Replacement Therapy Trial in Montpellier (Lowering sodium concentration dialysate, Highing sodium
Recruiting
- Acute Kidney Injury
- Renal Replacement Therapy
- Lowering sodium concentration dialysate
- Highing sodium concentration dialysate
-
Montpellier, FranceUhmontpellier
Sep 16, 2022
Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,
Completed
- Hyperphosphatemia
- +2 more
- Ferric Citrate 1 gram Oral Tablet
- Standard of care phosphate-lowering therapy
-
Anchorage, Alaska
- +12 more
Nov 3, 2022
Familial Atherosclerosis Study-observational Study
Completed
- Carotid Stenosis
-
Seattle, WashingtonUniversity of Washington
Dec 1, 2021
Acute Ischemic Stroke Trial in Nanjing (Intensive BP lowering)
Recruiting
- Acute Ischemic Stroke
- Intensive BP lowering
-
Nanjing, Jiangsu, ChinaNanjing First Hospital, Nanjing Medical University
Apr 12, 2022
Malignant Abdominal Tumor, Malignant Head and Neck Tumor, Malignant Solid Tumor Trial in Houston (Behavioral Intervention, Best
Recruiting
- Malignant Abdominal Neoplasm
- +3 more
- Behavioral Intervention
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
Open Angle Glaucoma, Eye Diseases Trial in Guangzhou (RLRL therapy, Routine IOP-lowering medications)
Not yet recruiting
- Open Angle Glaucoma
- Eye Diseases
- RLRL therapy
- Routine IOP-lowering medications
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Mar 25, 2022
Coronary Artery Disease Trial in Kyoto, Tokyo (Pitavastatin 1 mg daily or 4 mg daily)
Completed
- Coronary Artery Disease
- Pitavastatin 1 mg daily or 4 mg daily
-
Kyoto, Japan
- +1 more
May 14, 2021
Type2 Diabetes, Coronary Heart Disease Trial in Portugal (Exposure to Anti-thrombotic treatment agents and glucose lowering
Active, not recruiting
- Type2 Diabetes Mellitus
- Coronary Heart Disease
- Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
-
Amadora, Lisbon, Portugal
- +11 more
Oct 26, 2021
Patients With High Cholesterol Levels Needing a Lipid-lowering Therapy Trial in Brussels (Genotyping)
Withdrawn
- Patients With High Cholesterol Levels Needing a Lipid-lowering Therapy
- Genotyping
-
Brussels, BelgiumSaint-Luc Hospital
Mar 16, 2021
Coronary Artery Disease, Carotid Artery Diseases, Atherosclerosis Trial in United States (Atorvastatin, Niacin, Colesevelam)
Completed
- Coronary Artery Disease
- +2 more
- Atorvastatin
- +4 more
-
Los Angeles, California
- +3 more
May 16, 2022
COPD, Urinary Incontinence Trial in Trondheim, Moss (Pelvic floor muscle training, Cough-suppression therapy, Control)
Completed
- Chronic Obstructive Pulmonary Disease
- Urinary Incontinence
- Pelvic floor muscle training
- +2 more
-
Trondheim, Norway
- +1 more
Mar 2, 2021
Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)
Active, not recruiting
- Homozygous Familial Hypercholesterolemia
-
Evanston, Illinois
- +11 more
Jul 13, 2022